Pamela Goldberg, the new CEO of the Medical Device Innovation Consortium, sat down with Medtech Insight two months after taking the reins from Bill Murray to chat about what she's focused on these days. The organization has proven to be very influential on US regulatory matters, and we delved into its work in Case for Quality, the National Evaluation System for Health Technology (NEST) Coordinating Center and early feasibility studies, among others.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?